Randomized Controlled Trial of sublingual versus rectal Misoprostol in the prevention of primary postpartum hemorrhage

Background: Over 25% of all maternal deaths, especially in low-income nations, are attributed to postpartum hemorrhage (PPH), in accordance with the World Health Organization(WHO). Most severe maternal morbidities, including extended hospital stays, the need for blood transfusions, and surgical operations that may result in the loss of reproductive function, are also caused by PPH.